Merck will discontinue its drug for a bacterial infection that can lead to fatal diarrhea, the U.S. Food and Drug Administration's website showed on Monday.

Highly pathogenic avian influenza: considerations for healthcare settings

Join our weekly Rethinking Clinical Trials webinars on Fridays from 1-2 pm ET. Open to the public; no registration required. Join our mailing list Dr. Sumit Agarwal discusses “The Effect […]